Trial intelligence / Profile preview

Remimazolam vs propofol for hypoxemia during painless gastroscopy in elderly patients

ChiCTR2200056111Phase 4Not yet recruiting

Sponsor
Qilu Hospital of Shandong University
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in anoxemia (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Heart rate, Blood pressure and 3 more. Planned start Jul 2021; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

anoxemia

Beyond the preview

Go deeper on ChiCTR2200056111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200056111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call